Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination

Immunologic Research

Volumn 65, Issue 1, 2017, Pages 282-284

  Blitshteyn, Svetlana ^a   Brook, Jill ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti NMDA receptor antibodies; Human papillomavirus vaccination; Orthostatic intolerance; Plasmapheresis; Postural tachycardia syndrome

Indexed keywords

MUSCARINIC M2 RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PREDNISONE; WART VIRUS VACCINE; ANTIBODY; HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18; IMMUNOLOGIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AROUSAL; ARTICLE; BLOOD PRESSURE; CASE REPORT; CHRONIC FATIGUE SYNDROME; CONFUSION; DIZZINESS; DRUG DOSE REDUCTION; ELECTROMYOGRAPHY; FATIGUE; FEMALE; HEART RATE; HUMAN; IMMUNOMODULATION; NAUSEA; PAPILLOMAVIRUS INFECTION; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRESYNCOPE; PRIORITY JOURNAL; SLEEP DISORDER; SORE THROAT; VISUAL DISORDER; YOUNG ADULT; ADOLESCENT; BLOOD; CHEMICALLY INDUCED; IMMUNOLOGY; VACCINATION;

ADOLESCENT; ANTIBODIES; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; PAPILLOMAVIRUS VACCINES; PLASMAPHERESIS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; RECEPTORS, N-METHYL-D-ASPARTATE; VACCINATION;

EID: 84983396411     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-016-8855-1     Document Type: Article

References (10)

1. Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007;82:308–13.
2. Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.
3. Blitshteyn S. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol. 2014;21:135–9.
4. Brinth L, Thiebel AC, Pors K, Melson J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J. 2015;62:A5064.
5. Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755. doi:10.1161/JAHA.113.000755.
6. Dubey D, Hopkins S, Vernino S. M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis. 2016;17:99–180 Abstract.
7. Dahan S, Tomljenovic L, Shoenfeld Y. Postural orthostatic tachycardia syndrome (POTS): a novel member of the autoimmune family. Lupus. 2016;25:339–42.
8. Hendrickson JE, Tormey CA. Human papilloma virus vaccination and dysautonomia: consideration for autoantibody evaluation and HLA typing. Vaccine. 2016;34:4468.
9. Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015;24:1364–9.
10. Hofmann C, Baur M-O, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2011;258:500–1.